New hope for tough lymphomas: experimental drug STP938 enters human trials
NCT ID NCT05463263
First seen Apr 24, 2026 · Last updated May 17, 2026 · Updated 2 times
Summary
This study tests a new drug called STP938 in adults with B-cell or T-cell lymphoma that has returned or not responded to at least two prior treatments. The goal is to find a safe dose and see if the drug can shrink tumors. About 180 participants will take the drug alone, first in a dose-finding phase, then in a phase that looks at how well it works for different lymphoma types.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LYMPHOMA, B-CELL are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
CHU de Nantes
RECRUITINGNantes, France
Contact
-
Churchill Hospital
RECRUITINGOxford, United Kingdom
Contact
-
Colorado Blood Cancer Institute
RECRUITINGDenver, Colorado, 80218, United States
Contact
-
Derriford Hospital
RECRUITINGPlymouth, United Kingdom
Contact
-
Florida Cancer Specialists
RECRUITINGSarasota, Florida, 34232, United States
Contact
-
Hôpital Saint-Louis
RECRUITINGParis, Paris, 75610, France
Contact
Contact
-
Imperial College / Clinical Trials Unit, Hammersmith Hospital
RECRUITINGLondon, United Kingdom
Contact Phone: •••-•••-••••
-
Institut Gustave Roussy
RECRUITINGVillejuif, France
Contact
-
Institut Paoli Calmettes
RECRUITINGMarseille, France
Contact Phone: •••-•••-••••
Contact
-
Memorial Sloan Kettering
RECRUITINGNew York, New York, 10065, United States
Contact Phone: •••-•••-••••
Contact
-
Nottingham City Hospital
RECRUITINGNottingham, United Kingdom
Contact
-
The Centre Léon Bérard
RECRUITINGLyon, France
Contact
-
The Christie
RECRUITINGManchester, United Kingdom
Contact
-
The Royal Marsden
RECRUITINGSutton, United Kingdom
Contact Email: •••••@•••••
-
University Hospitals of Leicester NHS Trust
RECRUITINGLeicester, United Kingdom
Contact
Conditions
Explore the condition pages connected to this study.